Evidence map›Paper›PMID 28538675›Full record

ArticleMolecules (Basel, Switzerland)2017

Secondary Sulfonamides as Effective Lactoperoxidase Inhibitors.

Zeynep Köksal, Ramazan Kalin, Yasemin Camadan, Hande Usanmaz, Züleyha Almaz, İlhami Gülçin, Taner Gokcen, Ahmet Ceyhan Gören, Hasan Ozdemir

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Special Issue: Sulfonamides.Molecules (Basel, Switzerland) · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Zeynep KöksalDepartment of Chemistry, Faculty of Sciences, İstanbul Medeniyet University, 34730 İstanbul, Turkey. zeynep.koksal@medeniyet.edu.tr.
Ramazan KalinDepartment of Chemistry, Faculty of Science, Ataturk University, 25240 Erzurum, Turkey. rkalin@atauni.edu.tr.
Yasemin CamadanPharmacy Services Program, Vocational School of Health Services, Artvin Coruh University, 08000 Artvin, Turkey. yasem_can@hotmail.com.
Hande UsanmazDepartment of Bioengineering, Faculty of Engineering and Architecture, Sinop University, 57000 Sinop, Turkey. husanmaz@sinop.edu.tr.
Züleyha AlmazDepartment of Molecular Biology and Genetics, Faculty of Sciences and Arts, Muş Alparslan University, 49250 Muş, Turkey. z.turkoglu@alparslan.edu.tr.
İlhami GülçinDepartment of Chemistry, Faculty of Science, Ataturk University, 25240 Erzurum, Turkey. igulcin@atauni.edu.tr.
Taner GokcenTUBITAK UME, Chemistry Group Laboratories, P.O. Box: 54, 41470 Gebze Kocaeli, Turkey. taner.gokcen@tubitak.gov.tr.
Ahmet Ceyhan GörenTUBITAK UME, Chemistry Group Laboratories, P.O. Box: 54, 41470 Gebze Kocaeli, Turkey. ahmet.goren@acgpubs.org.
Hasan OzdemirDepartment of Chemistry, Faculty of Science, Ataturk University, 25240 Erzurum, Turkey. hozdemir@atauni.edu.tr.
Atatürk University · TRTübitak National Metrology Institute · TRArtvin Coruh University · TRErzurum Technical University · TRIstanbul Medeniyet University · TRMuş Alparslan University · TRSinop University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Secondary sulfonamides (

Indexed as

Anti-Bacterial AgentsEnzyme InhibitorsIsoxazolesLactoperoxidasePyridinesPyrimidinesSulfonamidesThiadiazolesAnti-Bacterial AgentsEnzyme InhibitorsIsoxazolesLactoperoxidasepyridinePyridinespyrimidinePyrimidinesSulfonamidesThiadiazolesenzyme inhibitionenzyme purificationlactoperoxidasesecondary sulfonamide

Identifiers

PMID28538675
PMCPMC6152724
OpenAlexW2618953123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.